文献速递心脑血管急症重症综合管理与镇静镇痛

IV tPA后早期神经功能恶化与症状性颅内出血的原因、预测因素和时机

Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA.
PubMed 文献 · Neurocrit Care · 2021-07-06
一句话结论IV tPA后sICH和END比例低且多发生于12小时内,无大血管闭塞的稳定患者或可早期降级监护。

本研究分析1238例发病4.5小时内接受IV tPA且未急性处理大血管闭塞的AIS患者,END定义为24小时内NIHSS评分下降≥4分(伴或不伴sICH)。结果sICH仅2.7%、任何ICH 9.4%、END 7.4%,END中63.7%无ICH;END平均发生于242±251分钟。END预测因素包括高龄、吸烟史、高脂血症及未治疗的大血管闭塞;任何ICH预测因素为高龄、更高基线NIHSS和更高基线血糖。作者认为临床稳定且无大血管闭塞的tPA后患者或可早期降级高 acuity 监护。

要点

  • 1238例接受IV tPA的AIS患者中,sICH仅2.7%(33例),任何ICH 9.4%(116例),END 7.4%(91例)。
  • END患者中63.7%无ICH,提示END多数非出血所致。
  • END平均发生时间为242±251分钟(约4±4小时),sICH和END通常发生在tPA后12小时内。
  • 任何ICH预测因素:高龄(74.6±12.4 vs 68.8±15.1,p=0.001)、更高基线NIHSS(14.6±7.3 vs 10.8±7.9,p=0.002)、更高基线血糖(155.1±87.5 vs 140.4±70.5,p=0.04);sICH因样本小(33例)无法确定预测因素。

适用人群与场景

  • 发病4.5小时内最后正常时间明确、接受IV tPA的急性缺血性卒中患者,且未急性处理大血管闭塞。
  • 研究纳入1238例此类患者;原文未明确列出其他纳入/排除标准。

诊断标准与关键阈值

  • END定义:24小时内NIHSS评分下降≥4分(伴或不伴sICH)。
  • sICH定义:原文未给出具体诊断标准。
  • 任何ICH包括非增强CT上任何程度的颅内出血,分为PH1或PH2。

处置流程与药物剂量

  • 原文未提及具体药物剂量或处置流程;仅提及当前指南推荐tPA治疗后24小时综合卒中监护(多为ICU)。
  • 原文结论提示:对临床稳定且无大血管闭塞的tPA后患者,可考虑早期降级高 acuity 监护,但未给出具体降级标准或流程。

红旗征与不能漏的情况

  • END(24小时内NIHSS下降≥4分)多发生于tPA后平均242±251分钟,需在此期间密切监测。
  • 任何ICH的预测因素包括高龄、更高基线NIHSS和更高基线血糖,此类患者出血风险更高。
  • END多数无ICH(63.7%),但仍需警惕sICH可能。

研究设计与关键结果

  • 研究类型:回顾性分析(原文未明确说明设计类型,仅描述为分析患者)。
  • 样本量与中心数:1238例患者,中心数原文未提及。
  • 人群:发病4.5小时内接受IV tPA的AIS患者,未急性处理大血管闭塞。
  • 主要终点:sICH 2.7%(33例),任何ICH 9.4%(116例),END 7.4%(91例),END中63.7%无ICH。
  • END平均时间242±251分钟。
  • 任何ICH预测因素:高龄(p=0.001)、更高基线NIHSS(p=0.002)、更高基线血糖(p=0.04)。
  • sICH因样本量小(33例)无法确定预测因素。

证据类型、等级与局限

  • 证据类型:回顾性分析(原文未明确标注为RCT或队列研究)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:sICH样本量小(33例)无法确定预测因素;原文未提及其他局限。

对床旁实践的改变

  • 对临床稳定且无大血管闭塞的IV tPA后患者,可考虑早期降级高 acuity 监护,但需结合END和ICH预测因素个体化评估。
  • END多发生于tPA后12小时内(平均约4小时),监测应至少覆盖此时间段。
  • END多数无ICH,评估神经功能恶化时应同时考虑非出血性原因。
  • 不适用人群:有大血管闭塞且未治疗者END风险更高(OR 2.1),可能不适合早期降级。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Acute ischemic stroke (AIS) is a major contributor toward healthcare-associated costs and services. Symptomatic intracranial hemorrhage (sICH) and early neurologic decline (END), defined as a National Health Institute Stroke Scale score decline of ≥ 4 within 24 h (with or without sICH), remain major concerns when administering intravenous tissue plasminogen activator (IV tPA) despite improved functional neurologic outcomes with its use. Given these risks, current guidelines recommend comprehensive stroke care (most often in an intensive care unit setting) for 24 h posttreatment. However, a number of patients may remain stable after IV tPA and thus not require such intensive resources. We sought to determine causes of END, along with timing and predictors of both sICH and END, to identify patients at lower risk of neurological deterioration and those suitable for earlier transition to a lower level of care.

METHODS: This present study analyzed patients with AIS that presented within 4.5 h of being last seen well and received IV tPA. Baseline demographic, clinical, and radiographic findings were collected. Outcomes included END from any cause, parenchymal hemorrhage (PH1 or PH2), sICH, and mortality at 90 days.

RESULTS: A total of 1238 patients with AIS without acute treatment of large vessel occlusion received IV tPA. 9.4% (116) had presence of any degree of ICH on noncontrast computed tomography head and 7.4% (91) experienced associated END. 2.7% (33) of patients experienced sICH, while 6.7% (83) experienced asymptomatic ICH. Of the patients with END, 63.7% did not have ICH. Predictive factors at presentation for END included an older age (72.6 ± 16.1 vs. 69.1 ± 14.8, p = 0.03), history of tobacco use (odds ratio [OR] 2.1 [1.1-4.3], p = 0.04), and hyperlipidemia (OR 1.7 [1.1-2.8], p = 0.02), along with the presence of an untreated large vessel occlusion (OR 2.1 [1.4-3.1], p = 0.02). Most END occurred within a mean time of 242 ± 251 min (4 ± 4 h). Because of the small proportion of patients suffering from sICH (33), predictors could not be determined; however, for patients with any ICH, predictive factors included an older age (74.6 ± 12.4 vs. 68.8 ± 15.1, p = 0.001), higher baseline National Health Institute Stroke Scale score (14.6 ± 7.3 vs. 10.8 ± 7.9, p = 0.002), and higher baseline glucose levels (155.1 ± 87.5 vs. 140.4 ± 70.5, p = 0.04).

CONCLUSIONS: In this study, only a small proportion suffered from either sICH and/or END, typically within 12 h of tPA administration. These findings may support earlier deescalation of higher acuity monitoring in clinically stable post-IV tPA patients without large vessel occlusion.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Shah K, Clark A, Desai SM, et al. Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA. Neurocrit Care. 2021. PMID: 34228264. doi:10.1007/s12028-021-01266-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。